Inhibition of Cardiac Ca2+ Release Channels (RyR2) Determines Efficacy of Class I Antiarrhythmic Drugs in Catecholaminergic Polymorphic Ventricular Tachycardia
Circulation: Arrhythmia and Electrophysiology- United States
doi 10.1161/circep.110.959916
Full Text
Abstract
Available in
Date
April 1, 2011
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)